Literature DB >> 23043049

Late stent thrombosis of a second-generation drug- eluting stent.

Pasi P Karjalainen1, Wail Nammas, Antti Ylitalo.   

Abstract

A 62-year-old male patient presented with acute non-ST elevation myocardial infarction. He underwent successful percutaneous coronary intervention with implantation of an everolimus-eluting stent in the left anterior descending coronary artery. Six months later, he discontinued clopidogrel. Two weeks later, he presented with unstable angina. Despite the unremarkable electrocardiography, cardiac biomarkers, and coronary angiography, optical coherence tomography revealed a thrombus extending throughout the stent, with uncovered and malapposed stent struts in its proximal part. Thrombectomy was performed. The patient was discharged on dual antiplatelet therapy. Eight months later, the follow-up coronary angiography reassured a patent stent with adequate flow and no evidence of thrombi.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23043049

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN: 1042-3931            Impact factor:   2.022


  1 in total

1.  Safety and efficacy of biolimus-eluting stent with biodegradable polymer: insights from EINSTEIN (Evaluation of Next-generation drug-eluting STEnt IN patients with coronary artery disease) Registry.

Authors:  Cristiano Freitas de Souza; Anwar Mohamed El Mouallem; Fábio Sândoli de Brito Júnior; Alexandre Antônio Cunha Abizaid; Breno Oliveira Almeida; Amanda Gonçalves Almeida; Teresa Cristina Dias Cunha Nascimento; Marco Antonio Perin; Adriano Caixeta
Journal:  Einstein (Sao Paulo)       Date:  2013 Jul-Sep
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.